Publication Summary
AVENE
An emollient PLUS balm is useful for the management of xerosis in cancer-treated patients: a real-world, prospective, observational, multicenter study
Dermatologic and Therapy Journal
2022
This emollient was effective at reducing the severity of xerosis and other clinical symptoms, and at lessening the impact of skin manifestations on patient quality of life, regardless of the anticancer therapy received by the patient.
The product can be useful in the supportive care of cancer-treated patients who develop xerosis, regardless of the anticancer treatment they have received.
Our other publications on this subject
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.